Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Fitch

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Journal of Clinical Investigation|September 1, 1995
Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulationC S Rinder, H M Rinder, B R Smith, et al.
Biophysical Journal|October 1, 1994
Measurement and global analysis of the absorbance changes in the photocycle of the photoactive yellow protein from Ectothiorhodospira halophilaW D Hoff, I H van Stokkum, H J van Ramesdonk, et al.
Circulation|December 22, 1999
Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypassJ C Fitch, S Rollins, L Matis, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Journal of Clinical Investigation|September 1, 1995
Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulationC S Rinder, H M Rinder, B R Smith, et al.
Biophysical Journal|October 1, 1994
Measurement and global analysis of the absorbance changes in the photocycle of the photoactive yellow protein from Ectothiorhodospira halophilaW D Hoff, I H van Stokkum, H J van Ramesdonk, et al.
Circulation|December 22, 1999
Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypassJ C Fitch, S Rollins, L Matis, et al.
Pageof 2